rs2234487
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004738.5(VAPB):c.315+35C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.414 in 1,041,992 control chromosomes in the GnomAD database, including 92,965 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14311 hom., cov: 32)
Exomes 𝑓: 0.41 ( 78654 hom. )
Consequence
VAPB
NM_004738.5 intron
NM_004738.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.731
Publications
14 publications found
Genes affected
VAPB (HGNC:12649): (VAMP associated protein B and C) The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
VAPB Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosis type 8Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- adult-onset proximal spinal muscular atrophy, autosomal dominantInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-58434740-C-T is Benign according to our data. Variant chr20-58434740-C-T is described in ClinVar as Benign. ClinVar VariationId is 259537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VAPB | NM_004738.5 | c.315+35C>T | intron_variant | Intron 3 of 5 | ENST00000475243.6 | NP_004729.1 | ||
| VAPB | NM_001195677.2 | c.212-9337C>T | intron_variant | Intron 2 of 2 | NP_001182606.1 | |||
| VAPB | NR_036633.2 | n.443-6167C>T | intron_variant | Intron 2 of 3 | ||||
| VAPB | XR_001754433.3 | n.546+35C>T | intron_variant | Intron 3 of 5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.431 AC: 65360AN: 151634Hom.: 14302 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65360
AN:
151634
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.413 AC: 99828AN: 241560 AF XY: 0.416 show subpopulations
GnomAD2 exomes
AF:
AC:
99828
AN:
241560
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.411 AC: 365532AN: 890238Hom.: 78654 Cov.: 12 AF XY: 0.411 AC XY: 191803AN XY: 466374 show subpopulations
GnomAD4 exome
AF:
AC:
365532
AN:
890238
Hom.:
Cov.:
12
AF XY:
AC XY:
191803
AN XY:
466374
show subpopulations
African (AFR)
AF:
AC:
9392
AN:
22374
American (AMR)
AF:
AC:
13484
AN:
43618
Ashkenazi Jewish (ASJ)
AF:
AC:
9295
AN:
22664
East Asian (EAS)
AF:
AC:
23234
AN:
36830
South Asian (SAS)
AF:
AC:
26686
AN:
74306
European-Finnish (FIN)
AF:
AC:
25469
AN:
49148
Middle Eastern (MID)
AF:
AC:
1757
AN:
4296
European-Non Finnish (NFE)
AF:
AC:
239370
AN:
595422
Other (OTH)
AF:
AC:
16845
AN:
41580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
9762
19524
29287
39049
48811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4860
9720
14580
19440
24300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.431 AC: 65409AN: 151754Hom.: 14311 Cov.: 32 AF XY: 0.437 AC XY: 32416AN XY: 74152 show subpopulations
GnomAD4 genome
AF:
AC:
65409
AN:
151754
Hom.:
Cov.:
32
AF XY:
AC XY:
32416
AN XY:
74152
show subpopulations
African (AFR)
AF:
AC:
17705
AN:
41346
American (AMR)
AF:
AC:
5588
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
1452
AN:
3468
East Asian (EAS)
AF:
AC:
3033
AN:
5180
South Asian (SAS)
AF:
AC:
1721
AN:
4806
European-Finnish (FIN)
AF:
AC:
5764
AN:
10494
Middle Eastern (MID)
AF:
AC:
125
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28755
AN:
67912
Other (OTH)
AF:
AC:
843
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1907
3815
5722
7630
9537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1567
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Amyotrophic lateral sclerosis type 8 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Adult-onset proximal spinal muscular atrophy, autosomal dominant Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.